J
J. Russell Geyer
Researcher at Seattle Children's
Publications - 62
Citations - 5319
J. Russell Geyer is an academic researcher from Seattle Children's. The author has contributed to research in topics: Survival rate & Radiation therapy. The author has an hindex of 36, co-authored 62 publications receiving 4868 citations. Previous affiliations of J. Russell Geyer include Children's National Medical Center & University of Washington.
Papers
More filters
Journal ArticleDOI
Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study
Paul M. Zeltzer,James M. Boyett,Jonathan L. Finlay,A. Leland Albright,L B Rorke,Jerrold M. Milstein,Jeffrey C. Allen,Kenneth R. Stevens,P Stanley,Hao Li,Jeffrey H. Wisoff,J. Russell Geyer,Patsy McGuire-Cullen,James A. Stehbens,Susan B. Shurin,Roger J. Packer +15 more
TL;DR: VCPplus XRT is a superior adjuvant combination compared with 8-in-1 chemotherapy plus XRT, and for patients with M0 tumors, residual tumor bulk (not extent of resection) is a predictor for PFS.
Journal ArticleDOI
Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services.
TL;DR: In this paper, the authors identify trends over the past two decades in the pattern of deaths attributable to pediatric CCCs, examining counts and rates of CCC-attributed deaths by cause and age (infancy: <1 year old, childhood: 1-9 years old, adolescence or young adulthood: 10-24 years old) at the time of death, and to determine the average number of children living within the last 6 months of their lives.
Journal ArticleDOI
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Adam M. Fontebasso,Simon Papillon-Cavanagh,Jeremy Schwartzentruber,Hamid Nikbakht,Noha Gerges,Pierre Fiset,Denise Bechet,Damien Faury,Nicolas De Jay,Lori A. Ramkissoon,Aoife Corcoran,David T.W. Jones,Dominik Sturm,Pascal Johann,Tadanori Tomita,Stewart Goldman,Mahmoud Nagib,Anne Bendel,Liliana Goumnerova,Daniel C. Bowers,Jeffrey R. Leonard,Joshua B. Rubin,Tord D. Alden,Samuel R. Browd,J. Russell Geyer,Sarah Leary,George I. Jallo,Kenneth J. Cohen,Nalin Gupta,Michael D. Prados,Anne Sophie Carret,Benjamin Ellezam,Louis Crevier,Almos Klekner,László Bognár,Peter Hauser,Miklós Garami,John S. Myseros,Zhifeng Dong,Peter M. Siegel,Hayley Malkin,Azra H. Ligon,Steffen Albrecht,Stefan M. Pfister,Keith L. Ligon,Jacek Majewski,Nada Jabado,Mark W. Kieran +47 more
TL;DR: Global DNA methylation profiles were significantly associated with the p.Lys27Met alteration, regardless of the mutant histone H3 variant and irrespective of tumor location, supporting the role of this substitution in driving the epigenetic phenotype.
Journal ArticleDOI
Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group
J. Russell Geyer,Richard Sposto,Mark T. Jennings,James M. Boyett,Richard A. Axtell,David Breiger,Emmett Broxson,Bernadine Donahue,Jonathan L. Finlay,Joel W. Goldwein,Linda Heier,Dennis L. Johnson,Claire Mazewski,Douglas C. Miller,Roger J. Packer,Diane Puccetti,Jerilynn Radcliffe,May Lin Tao,Tania Shiminski-Maher +18 more
TL;DR: Intensified induction chemotherapy resulted in a high response rate of malignant brain tumors in infants and survival was comparable to that of previous studies, and most patients who survived did not receive radiation therapy.
Journal ArticleDOI
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group
Patricia L. Robertson,Paul M. Zeltzer,James M. Boyett,Lucy B. Rorke,Jeffrey C. Allen,J. Russell Geyer,Philip Stanley,Hao Li,A. Leland Albright,Patricia McGuire-Cullen,Jonathan L. Finlay,Kenneth R. Stevens,Jerrold M. Milstein,Roger J. Packer,Jeffrey H. Wisoff +14 more
TL;DR: The pattern of predominantly local relapse and the important influence of residual tumor or the extent of resection on PFS duration confirms a prevailing impression that local disease control is the major factor in the prediction of outcome of ependymoma.